A report on testing for severe combined immune deficiency (SCID) in New Zealand as part of the Newborn Metabolic Screening Programme. It was prepared for the National Screening Unit by Health Partners Consulting Group Ltd.
This literature review was intended to inform an economic analysis of the cost-effectiveness of including testing for Severe Combined Immune Deficiency (SCID) in the Newborn Metabolic Screening Programme. It was prepared for the National Screening Unit by Health Partners Consulting Group Ltd.